Public health guidance: Seasonal influenza vaccination of children and pregnant women
The aim of this guidance document is to provide EU/EEA Member States and EU bodies with relevant information to make an informed decision on routine vaccination of healthy children and pregnant women with seasonal influenza vaccine. The options presented in this document are based on a systematic review of the literature and the opinions of a group of independent experts.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA
This report presents the main findings of an ECDC project to assess the burden of infectious diseases among migrants in the EU/EEA based on available data for specific diseases: human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B, hepatitis C, gonorrhoea, syphilis, measles and rubella, malaria and Chagas disease.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA: Executive summary
Mumps: Burden of disease in FranceArchived
Mumps is not a notifiable disease in France, and this study provides useful information by combining different data sources. The current incidence of mumps is somewhat higher than the average European (9 versus 3.2 per 100 000 per year) and authors sugges
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study
In a large community study (Flu Watch), cohorts were prospectively studied across the UK during six periods (2006-2010) with the main aim to compare the burden and the severity of seasonal and pandemic influenza across different age groups over time.
Weekly Influenza Surveillance Overview (WISO) and new study presenting global estimates of the burden seasonal influenza in children publishedArchived
While Europe is experiencing low influenza activity a new study presenting global estimates of the burden of respiratory infections due to seasonal influenza in young children has been published online by the Lancet on the 11 November 2011
Hepatitis B and C testing activities, needs, and priorities in the EU/EEA
ECDC undertook a survey to assess needs and priorities prior to developing guidance on testing and screening for hepatitis B and C (HBV/HCV) in the EU/EEA, and to update the existing evidence on the burden of HBV/HCV morbidity and mortality across EU/EEA Member States.
Expert opinion on rotavirus vaccination in infancy
ECDC has published an Expert Opinion on rotavirus vaccination in infancy. The paper provides EU/EEA Member States with relevant scientific information on burden of rotavirus disease, vaccine effectiveness and safety, and cost-effectiveness studies to support the decision-making process on the possible introduction of routine vaccination of children against rotavirus gastroenteritis.
Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU/EEA
The elimination of tuberculosis (TB) in Europe will require the management of latent tuberculosis infection (LTBI) in key populations. Management of LTBI requires the identification and adequate treatment of infected people. It is currently unknown how screening and treatment of key populations should be best organised to have the highest impact with the available resources.